Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383099028> ?p ?o ?g. }
- W4383099028 endingPage "446" @default.
- W4383099028 startingPage "430" @default.
- W4383099028 abstract "Aim: This study aimed to decipher the molecular mechanism underlying the synergistic effect of inhibitors of the mevalonate-cholesterol pathway (i.e., statins) and aminopeptidase inhibitors (APis) on APi-sensitive and -resistant acute myeloid leukemia (AML) cells. Methods: U937 cells and their sublines with low and high levels of acquired resistance to (6S)-[(R)-2-((S)-Hydroxy-hydroxycarbamoyl-methoxy-methyl)-4-methyl-pentanoylamino]-3,3 dimethyl-butyric acid cyclopentyl ester (CHR2863), an APi prodrug, served as main AML cell line models. Drug combination effects were assessed with CHR2863 and in vitro non-toxic concentrations of various statins upon cell growth inhibition, cell cycle effects, and apoptosis induction. Mechanistic studies involved analysis of Rheb prenylation required for mTOR activation. Results: A strong synergy of CHR2863 with the statins simvastatin, fluvastatin, lovastatin, and pravastatin was demonstrated in U937 cells and two CHR2863-resistant sublines. This potent synergy between simvastatin and CHR2863 was also observed with a series of other human AML cell lines (e.g., THP1, MV4-11, and KG1), but not with acute lymphocytic leukemia or multiple solid tumor cell lines. This synergistic activity was: (i) specific for APis (e.g., CHR2863 and Bestatin), rather than for other cytotoxic agents; and (ii) corroborated by enhanced induction of apoptosis and cell cycle arrest which increased the sub-G1 fraction. Consistently, statin potentiation of CHR2863 activity was abrogated by co-administration of mevalonate and/or farnesyl pyrophosphate, suggesting the involvement of protein prenylation; this was experimentally confirmed by impaired Rheb prenylation by simvastatin. Conclusion: These novel findings suggest that the combined inhibitory effect of impaired Rheb prenylation and CHR2863-dependent mTOR inhibition instigates a potent synergistic inhibition of statins and APis on human AML cells." @default.
- W4383099028 created "2023-07-05" @default.
- W4383099028 creator A5005394469 @default.
- W4383099028 creator A5007946879 @default.
- W4383099028 creator A5013852274 @default.
- W4383099028 creator A5018592613 @default.
- W4383099028 creator A5031445293 @default.
- W4383099028 creator A5035296183 @default.
- W4383099028 creator A5049992488 @default.
- W4383099028 creator A5070729528 @default.
- W4383099028 date "2023-01-01" @default.
- W4383099028 modified "2023-10-18" @default.
- W4383099028 title "Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells" @default.
- W4383099028 cites W1495123612 @default.
- W4383099028 cites W1532920017 @default.
- W4383099028 cites W153618619 @default.
- W4383099028 cites W1844107241 @default.
- W4383099028 cites W1849728743 @default.
- W4383099028 cites W1866667399 @default.
- W4383099028 cites W196543165 @default.
- W4383099028 cites W1975286848 @default.
- W4383099028 cites W1977747566 @default.
- W4383099028 cites W1990136541 @default.
- W4383099028 cites W1990854324 @default.
- W4383099028 cites W2000502240 @default.
- W4383099028 cites W2002252224 @default.
- W4383099028 cites W2020617755 @default.
- W4383099028 cites W2026048257 @default.
- W4383099028 cites W2032189193 @default.
- W4383099028 cites W2037209279 @default.
- W4383099028 cites W2048214220 @default.
- W4383099028 cites W2058689898 @default.
- W4383099028 cites W2059716825 @default.
- W4383099028 cites W2069285055 @default.
- W4383099028 cites W2072318687 @default.
- W4383099028 cites W2079430799 @default.
- W4383099028 cites W2082472490 @default.
- W4383099028 cites W2084162137 @default.
- W4383099028 cites W2086528604 @default.
- W4383099028 cites W2092628520 @default.
- W4383099028 cites W2095177723 @default.
- W4383099028 cites W2100510340 @default.
- W4383099028 cites W2101100141 @default.
- W4383099028 cites W2101132650 @default.
- W4383099028 cites W2105961905 @default.
- W4383099028 cites W2108552233 @default.
- W4383099028 cites W2111607026 @default.
- W4383099028 cites W2111909718 @default.
- W4383099028 cites W2114164056 @default.
- W4383099028 cites W2115603990 @default.
- W4383099028 cites W2119540996 @default.
- W4383099028 cites W2120412593 @default.
- W4383099028 cites W2121215375 @default.
- W4383099028 cites W2123383613 @default.
- W4383099028 cites W2123960043 @default.
- W4383099028 cites W2124228127 @default.
- W4383099028 cites W2127207520 @default.
- W4383099028 cites W2130725183 @default.
- W4383099028 cites W2131276314 @default.
- W4383099028 cites W2131536053 @default.
- W4383099028 cites W2132319954 @default.
- W4383099028 cites W2137762225 @default.
- W4383099028 cites W2139192127 @default.
- W4383099028 cites W2155791857 @default.
- W4383099028 cites W2155834747 @default.
- W4383099028 cites W2156936195 @default.
- W4383099028 cites W2161160225 @default.
- W4383099028 cites W2162327900 @default.
- W4383099028 cites W2162657734 @default.
- W4383099028 cites W2256972210 @default.
- W4383099028 cites W2276982989 @default.
- W4383099028 cites W2285019053 @default.
- W4383099028 cites W2766243612 @default.
- W4383099028 cites W2982942741 @default.
- W4383099028 cites W3092281140 @default.
- W4383099028 cites W3093204654 @default.
- W4383099028 cites W3126185563 @default.
- W4383099028 cites W3137653025 @default.
- W4383099028 cites W3159038226 @default.
- W4383099028 cites W3208217676 @default.
- W4383099028 cites W4283526995 @default.
- W4383099028 cites W4327518388 @default.
- W4383099028 doi "https://doi.org/10.20517/cdr.2023.20" @default.
- W4383099028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37842233" @default.
- W4383099028 hasPublicationYear "2023" @default.
- W4383099028 type Work @default.
- W4383099028 citedByCount "0" @default.
- W4383099028 crossrefType "journal-article" @default.
- W4383099028 hasAuthorship W4383099028A5005394469 @default.
- W4383099028 hasAuthorship W4383099028A5007946879 @default.
- W4383099028 hasAuthorship W4383099028A5013852274 @default.
- W4383099028 hasAuthorship W4383099028A5018592613 @default.
- W4383099028 hasAuthorship W4383099028A5031445293 @default.
- W4383099028 hasAuthorship W4383099028A5035296183 @default.
- W4383099028 hasAuthorship W4383099028A5049992488 @default.
- W4383099028 hasAuthorship W4383099028A5070729528 @default.
- W4383099028 hasBestOaLocation W43830990281 @default.
- W4383099028 hasConcept C108634530 @default.